专利检索 ap:("Sarah Tate" OR "Gianpiero Cavalleri" OR "Stephanie Schorge" OR "Sanjay Sisodiya" OR "Nicholas Wood" OR "David Goldstein") AND inv:"Sarah Tate" 第 1 页

1.

发明申请
Genetic predictor for clinical use of drugs used in the treatment of neurological conditions 审中-公开
标题翻译：临床使用用于治疗神经病症的药物的遗传学预测因子

公开(公告)号：US20060269935A1

公开(公告)日：2006-11-30

申请号：US11377985

申请日：2006-03-17

申请人： Sarah Tate , Gianpiero Cavalleri , Stephanie Schorge , Sanjay Sisodiya , Nicholas Wood , David Goldstein

发明人： Sarah Tate , Gianpiero Cavalleri , Stephanie Schorge , Sanjay Sisodiya , Nicholas Wood , David Goldstein

IPC分类号： C12Q1/68

CPC分类号： C12Q1/6883 , C12Q2600/106 , C12Q2600/156 , C12Q2600/172

摘要： A method for determining the dosage regime of a drug suitable for use in the treatment of a neurological condition in a subject, which method comprises typing the SCN1A gene of the subject. The method may be used to determine the dosage regime of an anti-epileptic drug (AED) in a subject. A subject may be treated in accordance with the dosage regime determined using such a method.

摘要翻译： 一种用于确定适合用于治疗受试者神经病症的药物的剂量方案的方法，所述方法包括分型受试者的SCN1A基因。该方法可用于确定受试者中抗癫痫药（AED）的剂量方案。可以根据使用这种方法确定的剂量方案来治疗受试者。